The hexose transport system in the human K-562 chronic myelogenous leukemia-derived cell
✍ Scribed by J. C. Dozier; D. F. Diedrich; S. J. Turco
- Book ID
- 102309327
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 436 KB
- Volume
- 108
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Kinetics of glucose transport in K‐562 cells was studied using 3‐0‐methylglucose, a nonmetabolizable analog of glucose. A K~m~ of 3.7 mM and V~max~ of 32.0 nmoles/minute/10^6^ cells was found for the process. D‐Glucose, phloretin, and phlorizin competitively inhibit the transport of 3‐0‐methylglucose with Ki values of 4.1 mM, 4.1 μM and 225 μM, respectively, whereas L‐glucose did not inhibit transport at all. The results indicate that K‐562 cells, which are known to have erythropoietic characteristics, possess a glucose carrier system similar to the one in adult human erythrocytes. However, the V~max~ data suggest that more copies of the carrier are present in the malignant cell, presumably to support the high rate of anaerobic glycolysis.
📜 SIMILAR VOLUMES
Antineoplastic activity of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide) is mediated by an anabolite of the drug thiazole-4-carboxamide adenine dinucleotide (TAD), an analog of NAD which inhibits IMP dehydrogenase activity resulting in the depletion of guanylate pools and cell death. Hum
## Abstract The K562 cell line derived from a CML patient in blast crisis was examined for properties of B and T lymphocytes and cell lines. K562 lacks the B markers of immunoglobulin, Epstein‐Barr virus (EBV) genome and associated nuclear antigen, and receptors for EBV. A low proportion of cells f